Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Neonicotinoid pesticide reduces ovary development in bumblebee queens
Bumblebee
The study looked at the feeding behaviour and ovary development of four species of bumblebee queen.

Thiamethoxam also found to affect feeding behaviour

Wild bumblebee queens are less able to develop their ovaries when exposed to a common neonicotinoid pesticide, new research has found.

Writing in the journal Proceedings of the Royal Society B, researchers describe an investigation into the impact of exposure to field-realistic levels of thiamethoxam.

Conducted by a team at the Royal Holloway University of London, the study looked at the feeding behaviour and ovary development of four species of bumblebee queen.

“We consistently found that neonicotinoid exposure, at levels mimicking exposure that queens could experience in agricultural landscapes, resulted in reduced ovary development in queens of all four species we tested,” said lead author Dr Gemma Baron.

“Impacts of neonicotinoid exposure on feeding behaviour were species-specific, with two out of four species eating less artificial nectar when exposed to the pesticide. These impacts are likely to reduce the success of bumblebee queens in the spring, with knock-on effects for bee populations later in the year".

The study is the first of its kind to analyse the impacts of these chemicals across multiple bumblebee species. Previously, scientists have focused on a single bumblebee species and assessed impacts in workers and established colonies.

Thiamethoxam is a synthetic pesticide that is currently under an EU moratorium, together with two other neonicotinoids.

"The EU and other countries are weighing the benefits of using neonicotinoids to protect crops, against real concerns about how such pesticides can cause unintended harm to pollinators and other beneficial insects,” explained co-author Professor Raine.
“This work on wild bumblebee queens adds significantly to the evidence base on which to make such important policy decisions”.

The researchers add that their work provides a ‘major step forward’ in understanding the impacts of neonicotinoids on wild bees.

“Future studies across different species are likely to demonstrate further variation in the impact of neonicotinoids,” they conclude. “Conducting such studies needs to be a priority for scientists and governments”.

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.